참고문헌 (41)

1. 10.1248/yakushi1947.110.12_932 1) Yamahara J, Kitani T, Kobayashi H, Kawahara Y. 1990. Studies on Stachys sieboldii Miq. II. Anti-anoxia action and the active constituents. Yakugaku Zasshi 110: 932-935. 

   

2. 10.1248/yakushi1947.105.10_955 2) Takeda Y, Fujita T, Satoh T, Kakegawa H. 1985. On the glycosidic constituents of Stachys sieboldi Miq. and their effects on hyaluronidase activity. Yakugaku Zasshi 105: 955-959. 

   상세보기

3. 3) Hayashi K, Nagamatsu T, Ito M, Hattori T, Suzuki Y. 1994. Acteoside, a component of Stachys sieboldii Miq, may be a promising antinephritic agent (2): Effect of acteoside on leukocyte accumulation in the glomeruli of nephritic rats. Jpn J Pharmacol 66: 47-52. 

4. 10.1016/j.neures.2010.06.010 4) Kitamura E, Hamada J, Kanazawa N, Yonekura J, Masuda R, Sakai F, Mochizuki H. 2010. The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neurosci Res 68: 154-157. 

   상세보기

5. 10.1254/fpj.131.252 5) Suzuki N. 2008. Clinical application of dietary supplements. Nippon Yakurigaku Zasshi 131: 252-257. 

   상세보기

6. 6) Sahathevan R, Brodtmann A, Donnan GA. 2012. Dementia, stroke, and vascular risk factors; a review. Int J Stroke 7: 61-73. 

7. 10.1016/j.neulet.2013.02.001 7) Min D, Guo F, Zhu S, Xu X, Mao X, Cao Y, Lv X, Gao Q, Wang L, Chen T, Shaw C, Hao L, Cai J. 2013. The alterations of Ca2+/calmodulin/CaMKII/CaV1.2 signaling in experimental models of Alzheimer’s disease and vascular dementia. Neurosci Lett 538: 60-65. 

   상세보기

8. 10.2174/156720506775697106 8) Greenberg DA, Jin K. 2006. Neurodegeneration and neurogenesis: focus on Alzheimer’s disease. Curr Alzheimer Res 3: 25-28. 

   상세보기

9. 10.1073/pnas.0606298103 9) Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W. 2006. Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 103: 18727-18732. 

   상세보기

10. 10.3233/JAD-2001-3407 10) Luo Y. 2001. Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer’s disease. J Alzheimers Dis 3: 401-407. 

    상세보기

11. 10.1161/STROKEAHA.108.523480 11) Saleem S, Zhuang H, Biswal S, Christen Y, Dore S. 2008. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 39: 3389-3396. 

    상세보기

12. 12) van Beek TA, Montoro P. 2009. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. J Chromatogr A 1216: 2002-2032. 

13. 13) Smith JV, Burdick AJ, Golik P, Khan I, Wallace D, Luo Y. 2002. Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell Mol Biol (Noisy-le-grand) 48: 699-707. 

14. 10.3233/JAD-2003-5404 14) Smith JV, Luo Y. 2003. Elevation of oxidative free radicals in Alzheimer’s disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis 5: 287-300. 

    상세보기

15. 15) Gohil K, Packer L. 2002. Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761. Cell Mol Biol (Noisy-le-grand) 48: 625-631. 

16. 10.1001/archneur.55.11.1409 16) Oken BS, Storzbach DM, Kaye JA. 1998. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55: 1409-1415. 

    상세보기

17. 10.1007/s10863-009-9197-7 17) Shi C, Yao Z, Xu J, Yew DT. 2009. Effects of Gingko extract (EGb761) on oxidative damage under different conditions of serum supply. J Bioenerg Biomembr 41: 61-69. 

    상세보기

18. 10.1016/j.pbb.2005.04.019 18) Dunn AJ, Swiergiel AH. 2005. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav 81: 688-693. 

    상세보기

19. 10.1016/j.brainres.2013.09.041 19) Harada S, Yamazaki Y, Nishioka H, Tokuyama S. 2013. Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemia. Brain Res 1541: 61-68. 

    상세보기

20. 10.1016/j.brainres.2009.05.014 20) Harada S, Fujita WH, Shichi K, Tokuyama S. 2009. The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res 1279: 174-181. 

    상세보기

21. 10.1111/jphp.12007 21) Tamiya S, Yoshida Y, Harada S, Nakamoto K, Tokuyama S. 2013. Establishment of a central post-stroke pain model using global cerebral ischaemic mice. J Pharm Pharmacol 65: 615-620. 

    상세보기

22. 10.1248/bpb.35.624 22) Fujita-Hamabe W, Tokuyama S. 2012. The involvement of cleavage of neural cell adhesion molecule in neuronal death under oxidative stress conditions in cultured cortical neurons. Biol Pharm Bull 35: 624-628. 

    상세보기

23. 23) Wang SJ, Chen HH. 2005. Ginkgolide B, a constituent of Ginkgo biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminals. Eur J Pharmacol 514: 141-149. 

24. 10.1055/s-2007-981532 24) Bei W, Peng W, Zang L, Xie Z, Hu D, Xu A. 2007. Neuroprotective effects of a standardized extract of Diospyros kaki leaves on MCAO transient focal cerebral ischemic rats and cultured neurons injured by glutamate or hypoxia. Planta Med 73: 636-643. 

    상세보기

25. 10.1080/1028415021000055970 25) Sweeney MI, Kalt W, MacKinnon SL, Ashby J, Gottschall-Pass KT. 2002. Feeding rats diets enriched in lowbush blueberries for six weeks decreases ischemia-induced brain damage. Nutr Neurosci 5: 427-431. 

    상세보기

26. 10.1016/j.neuron.2010.07.002 26) Moskowitz MA, Lo EH, Iadecola C. 2010. The science of stroke: mechanisms in search of treatments. Neuron 67: 181-198. 

    상세보기

27. 10.1016/S0166-2236(99)01401-0 27) Dirnagl U, Iadecola C, Moskowitz MA. 1999. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391-397. 

    상세보기

28. 10.1016/0891-5849(89)90057-9 28) Hall ED, Braughler JM. 1989. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med 6: 303-313. 

    상세보기

29. 10.1161/01.STR.9.5.445 29) Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J. 1978. Free radicals in cerebral ischemia. Stroke 9: 445-447. 

    상세보기

30. 10.1016/0306-4522(90)90328-2 30) Kitagawa K, Matsumoto M, Oda T, Niinobe M, Hata R, Handa N, Fukunaga R, Isaka Y, Kimura K, Maeda H, Mikoshiba K, Kamada T. 1990. Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death. Neuroscience 35: 551-558. 

    상세보기

31. 10.1016/j.nut.2005.02.010 31) Chang CY, Chen JY, Ke D, Hu ML. 2005. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits. Nutrition 21: 987-993. 

    상세보기

32. 10.1016/j.neuroscience.2004.03.057 32) Zhang B, Tanaka J, Yang L, Sakanaka M, Hata R, Maeda N, Mitsuda N. 2004. Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1. Neuroscience 126: 433-440. 

    상세보기

33. 10.1093/jn/138.3.519 33) Ritz MF, Ratajczak P, Curin Y, Cam E, Mendelowitsch A, Pinet F, Andriantsitohaina R. 2008. Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke. J Nutr 138: 519-525. 

    상세보기

34. 10.1016/j.talanta.2006.03.027 34) Yin J, Yang G, Wang S, Chen Y. 2006. Purification and determination of stachyose in Chinese artichoke (Stachys sieboldii Miq.) by high-performance liquid chromatography with evaporative light scattering detection. Talanta 70: 208-212. 

    상세보기

35. 10.4161/psb.6738 35) Nishizawa-Yokoi A, Yabuta Y, Shigeoka S. 2008. The contribution of carbohydrates including raffinose family oligosaccharides and sugar alcohols to protection of plant cells from oxidative damage. Plant Signal Behav 3: 1016-1018. 

    상세보기

36. 10.1016/j.neuroscience.2013.07.014 36) Mishra N, Sasmal D, Singh KK. 2013. Attenuating Abeta1-42-induced toxicity by a novel acetylcholinesterase inhibitor. Neuroscience 250: 309-319. 

    상세보기

37. 37) Capurro V, Busquet P, Lopes JP, Bertorelli R, Tarozzo G, Bolognesi ML, Piomelli D, Reggiani A, Cavalli A. 2013. Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer’s disease. PLoS One 8: e56870. 

38. 10.1126/science.7046051 38) Bartus RT, Dean RL 3rd, Beer B, Lippa AS. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-414. 

    상세보기

39. 39) Gozes I, Giladi E, Pinhasov A, Bardea A, Brenneman DE. 2000. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J Pharmacol Exp Ther 293: 1091-1098. 

40. 10.1046/j.1365-2362.1998.00393.x 40) Ebert U, Kirch W. 1998. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 28: 944-949. 

    상세보기

41. 10.1007/s12640-011-9292-5 41) Wang HQ, Xu YX, Zhu CQ. 2012. Upregulation of heme oxygenase-1 by acteoside through ERK and PI3 K/Akt pathway confer neuroprotection against beta-amyloid-induced neurotoxicity. Neurotox Res 21: 368-378. 

    상세보기